Managing diabetes involves daily blood sugar monitoring, specialized devices, and medications like insulin, so understanding ...

Bio-Path Holdings Inc.’s stock (BPTH) soared over 150% Thursday afternoon, hitting levels last seen in August, making it the ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Bio-Path Holdings (BPTH) reported that results from preclinical studies of BP1001-A for obesity demonstrated enhanced insulin ...

Here’s what you need to know. What To Know: The preclinical studies demonstrated that BP1001-A enhances insulin sensitivity ...